SharpePoint’s Crown Castle CCI Stock Holding History

SharpePoint’s Portfolio CCI Stock Details CCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,474	Closed	-$225K	–	78
2024 Q4	$225K	Buy	+2,474	New	+$259K	0.2%	67

Other funds holding CCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SharpePoint's CCI Position: Q1 2025 in Review

SharpePoint sold out of Crown Castle (CCI) in Q1 2025, closing a stake of 2,474 shares — an estimated $225K sold.

SharpePoint first reported a position in CCI in Q4 2024 and held it in 1 quarter. The position peaked at $225K in Q4 2024. 1,103 funds tracked by Wall St. Rank hold CCI as of Q1 2025.

SharpePoint reported no remaining Crown Castle position as of Q1 2025 after selling out during the quarter.
SharpePoint sold 2,474 Crown Castle shares in Q1 2025, an estimated $225K.
SharpePoint first reported a position in Crown Castle in Q4 2024 and held it in 1 quarter.
SharpePoint's Crown Castle position peaked at $225K in Q4 2024.
1,103 funds tracked by Wall St. Rank held Crown Castle as of Q1 2025.

Based on SharpePoint's 13F filing for Q1 2025, filed 30 Apr 2025.